Caissa Capital Management ltd. - May 18, 2023 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
10%+ Owner
Signature
Cambyz Golestaneh, Title: Director
Stock symbol
AVTX
Transactions as of
May 18, 2023
Transactions value $
$89,372
Form type
4
Date filed
5/22/2023, 04:30 PM
Previous filing
May 16, 2023
Next filing
May 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common stock Purchase $43.2K +13.1K +0.97% $3.29* 1.36M May 18, 2023 See Footnote (1) F1, F2
transaction AVTX Common stock Purchase $22.9K +6.5K +0.48% $3.52* 1.37M May 19, 2023 See Footnote (1) F1, F3
transaction AVTX Common stock Purchase $23.4K +7K +0.51% $3.34* 1.37M May 22, 2023 See Footnote (1) F1, F4
holding AVTX Common stock 182K May 18, 2023 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.80 to $3.40, inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.4 to $3.6, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.00 to $3.72, inclusive.
F5 These share are directly owned by Mr. Golestaneh in his personal capacity.